The Predictability of Intraoperative Rotational Thromboelastometry on Postoperative Bleeding and Transfusion Requirements
Study Details
Study Description
Brief Summary
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
patients who underwent surgery for congenital heart disease patients who underwent surgery for congenital heart disease in 2013 at Samsung Medical Center |
Procedure: surgery for congenital heart disease with cardiopulmonary bypass
surgery for congenital heart disease with cardiopulmonary bypass
|
Outcome Measures
Primary Outcome Measures
- postoperative blood loss [during seven days after surgery]
daily blood loss measured by chest tube drainage during seven days after surgery
Secondary Outcome Measures
- postoperative transfusion requirements [during seven days after surgery]
postoperative transfusion requirements during seven days after surgery
Eligibility Criteria
Criteria
Inclusion Criteria:
- pediatric patients (< 10 years) who underwent surgery for congenital heart disease with cardiopulmonary bypass in 2013 at Samsung Medical Center
Exclusion Criteria:
- incomplete data about blood loss count or transfusion requirements during seven days after surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Samsung Medical Center | Seoul | Korea, Republic of | 135-710 |
Sponsors and Collaborators
- Samsung Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2013-12-096